2010-12-20 00:00:00,Gilead To Acquire Arresto Biosciences For Million
2011-02-07 00:00:00,Gilead Announces Notification of ANDA Filing for Tamiflu
2011-03-30 00:00:00,Gilead And Yale School of Medicine Announce Cancer Research Collaboration
2011-04-04 00:00:00,Hospitalization Not Cut By Gilead Heart
2011-10-24 00:00:00,Gilead And GlobeImmune Announce License And Collaboration Agreement to Develop Therapeutic Vaccine Products For Treatment of Chronic Hepatitis B Infection
2011-11-15 00:00:00,Gilead Finalizes Agreement With Tibotec Pharmaceuticals To Develop And Commercialize Regimen Of Prezista With Emtriva
2011-12-06 00:00:00,Gilead Prices Billion Of Senior Unsecured Notes
2011-12-09 00:00:00,Gilead Announces Data From Pivotal Phase 3 Study Of Elvitegravir
2011-12-15 00:00:00,Gilead Submits Supplemental New Drug Application To Food And Drug Administration For Truvada For Reducing Risk Of Acquiring HIV
2011-12-20 00:00:00,Gilead Files European Marketing Application For Quad
2011-12-22 00:00:00,JAPAN TOBACCO Signs License Contract for Cobicistat
2012-02-14 00:00:00,Gilead Announces FDA Grants Priority Review For Truvada For Reducing The Risk Of Acquiring HIV Infection
2012-03-09 00:00:00,Data Show Gilead Quad Regimen For HIV To Regimen At 48 Weeks In Second Pivotal Phase 3 Study
2012-05-01 00:00:00,Gilead Initiates Phase 3 Clinical Trial Evaluating For Treatment Of Chronic Lymphocytic Leukemia
2012-05-10 00:00:00,Gilead Reaffirms FY 2012 Net Sales Call
2012-06-27 00:00:00,Gilead Submits New Drug Application To FDA For HIV Integrase Inhibitor Elvitegravir For Treatment Experienced Patients
2012-08-27 00:00:00,FDA Approves Gilead Sciences Stribild
2012-10-11 00:00:00,Gilead Sciences Investment Recent Ratings Updates
2012-10-16 00:00:00,The Zacks Analyst Blog Arena Gilead Sciences
2012-10-17 00:00:00,RBC Capital Reaffirms Outperform Rating on Gilead Sciences
2012-10-25 00:00:00,Buy Gilead HIV And Hepatitis Drugs To Drive Growth
2012-10-26 00:00:00,Research Weekly Ratings Changes for Gilead Sciences
2012-10-31 00:00:00,Gilead Sciences Inc Phase 2 Clinical Trial Evaluating Tenofovir Alafenamide Fumarate Met Its Primary Objective
2012-11-06 00:00:00,Sanford Bernstein Reiterates Outperform on Gilead Sciences
